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2n the 1996 National Prevalence Survey of Smok-
ing Pattern in mainland China, the prevalence of
smoking was 66.9% in men and 4.2% in
omen; overall, 53.5% reported passive smoke expo-
ure. More than 72% of all Chinese (600 million
eople) are regularly exposed to either active smoking
r secondhand smoke (SHS) (1). As the world’s larg-
st producer and consumer of tobacco products,
hina bears a substantial burden of smoking-related
iseases and deaths (2). It is estimated that tobacco-
elated deaths will reach 7 million worldwide in 2025,
ith 2 million of these deaths predicted to occur in
hina (1,3). Tobacco smoking is a major risk factor
or cardiovascular disease (CVD) (4–7) and type 2
iabetes (8,9). Moreover, there is strong evidence that
assive smoking or SHS is causally associated with
oronary heart disease (CHD) (10–13) and may be
inked to stroke (14–16).
The metabolic syndrome (MetS) is characterized
y a clustering of cardiovascular risk factors, including
bdominal obesity, high blood pressure, increased
lucose level, and dyslipidemia. The MetS is associ-
ted with the development of diabetes and CVD
17,18) as well as an increased risk of CVD and all-
ause mortality (19,20). In China, it has become an
mportant public health problem with the prevalence
f MetS being 13.7% in the middle-aged (21) and o6.3% in the elderly (22) populations. There is also
vidence that SHS is associated with both MetS and
nsulin resistance (8,23–28). Although SHS has been
xamined as a risk factor for individual CVD (CHD
r stroke), it has not been investigated together with
etS in the Chinese population. In this study, we
xamined in detail the individual and combined ef-
ects of active smoking, SHS, and MetS on cardiovas-
ular risk in a population-based survey of elderly Chi-
ese in Beijing, China.
ethods
tudy population. We conducted a population-
ased cross-sectional survey of individuals age 60 years
r older in the Wanshoulu Community within the
aidian District, a metropolitan area representative of
he geographic and economic characteristics of Bei-
ing, China. A 2-stage stratified sampling method
as used. First, 9 residential communities (totaling
pproximately 300 to 600 households each) were se-
ected randomly from a total of 94 residential com-
unities in the Wanshoulu Area. Second, all individ-
als were chosen from selected streets within these
ommunities, but only 1 participant from each house-
old was invited to enroll in the study. From April
001 to March 2002, 2,680 people 60 years of age or
lder were selected and invited for screening. A total
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From Around the World January 27, 2009:363–71f 2,334 subjects (943 men and 1,391 women) completed
he survey, yielding a response rate of 87.1%, accounting
or 11.4% of the older residents in the Wanshoulu Area.
etails of data collection, physical examinations, and other
ests have been reported elsewhere (22).
The Committee for Medical Ethics of the Chinese PLA
eneral Hospital approved the study in 2001. Each partici-
ant signed an informed consent form before completing
he questionnaire.
ctive smoking and SHS exposure. The categories of
ctive smoking were: ever, former, and current smoker. An
ver smoker was defined as one who had smoked at least 1
igarette daily for 1 year or more. Current smokers were
ver smokers who were still smoking at the time of the in-
erview, and former smokers were those who had stopped
or at least 2 years. Individuals with no history of tobacco
moking were considered never smokers. Pack-years of
moking were calculated by multiplying the average num-
er of cigarettes smoked per day by the number of years of
moking and dividing by 20. SHS exposure was defined as
eing exposed to another person’s tobacco smoke at home
r in the workplace for at least 15 min daily more than 1
ay per week in the past 10 years (1).
efinitions. We defined MetS by using the International
iabetes Foundation (IDF) criteria of 2005 (29), which are
imilar to the modified U.S. National Cholesterol Educa-
ion Program’s Adult Treatment Panel III criteria (30). The
DF definition of MetS includes central obesity (waist cir-
umference 90 cm in Chinese men and 80 cm in Chi-
ese women) plus any 2 of the following 4 factors: 1) high
lood pressure: systolic130 mm Hg, diastolic85 mm Hg,
r known treatment for hypertension; 2) hypertriglyceridemia:
asting plasma triglycerides 1.7 mmol/l; 3) low high-
ensity lipoprotein cholesterol (HDL-C): fasting HDL-C
1.0 mmol/l in men and 1.3 mmol/l in women; and
) hyperglycemia: fasting glucose level of 5.6 mmol/l
100 mg/dl) or known treatment for diabetes.
Hypertension was defined as diastolic blood pressure of
90 mm Hg, systolic blood pressure of 140 mm Hg, or
urrent medication for hypertension. Coronary heart dis-
ase and stroke were defined using the World Health Orga-
ization’s MONICA (Multinational Monitoring of Trends
nd Determinants in Cardiovascular Disease) criteria (31).
yocardial infarction was defined by a representative set of
lectrocardiogram (ECG) changes, cardiac enzyme values,
nd typical symptoms. Angina was defined as use of nitro- (lycerin, experience of typical chest pain, or ECG changes
ompatible with ischemic heart disease. Strokes were de-
ned as events requiring hospitalization and confirmed by
ocal hospital records. CVD was defined by the presence of
HD and/or stroke.
tatistical analysis. Data were entered (double entry) and
anaged by Access (Microsoft Corp., Redmond, Washing-
on). The Wald chi-square analysis was used to determine
he sex-specific prevalence of MetS by tobacco exposure
tatus. Logistic regression was used to estimate the odds
atios (ORs) and 95% confidence interval (CI) of CVDs
ith adjustment for age, marital status, years of education,
lcohol consumption, hours per day of physical exercise,
otal cholesterol, and family history of CHD or stroke.
oth stratified analyses and multiple logistic regression
nalyses were used to examine the independent and
ombined effects of the tobacco exposure and MetS.
nteraction between tobacco exposure groups and MetS
tatus was investigated by adding interaction terms (to-
acco exposure status multiplied by MetS status) to the
ogistic regression model using the likelihood ratio test.
he statistical package used was SPSS (version 14.0,
PSS Inc., Chicago, Illinois).
esults
mong the study participants, there were 784 CHD patients,
ncluding 68 with myocardial infarction and 716 with stable
ngina. Among participants with CHD, 58% of the cases were
onfirmed by exercise test or B ultra-sound heart image. There
ere 378 cases of stroke (248 ischemic, 70 hemorrhagic, and
0 other types), and 83% of these events were confirmed by
omputed tomography and magnetic resonance imaging.
On the basis of the general characteristics of study par-
icipants, we found significant differences between men and
omen (Table 1). The prevalence of ever smoking was
uch greater in men (58.1%) than in women (13.1%), but
HS exposure was more likely in women (42.3% vs.
9.9%). On the basis of IDF criteria, MetS was present in
4.8% of men and 54.1% of women. Compared with never
mokers without exposure to SHS, the prevalence of individ-
al MetS components and MetS was greater in male active
mokers as well as in female active and passive smokers, partic-
larly, for low HDL-C and central obesity (Table 2).
Compared with never smokers without MetS, men with
etS had significantly greater risk of CVD among neverOR: 1.83; 95% CI: 1.17 to 2.86), former (OR: 2.24; 95%
C
C
M
O
s
e
a
o
h
t
s
i
a
0
t
w
s
s
esterol
365JACC Vol. 53, No. 4, 2009 He et al.
January 27, 2009:363–71 From Around the WorldI: 1.39 to 3.63), and current smokers (OR: 3.54; 95%
I: 2.03 to 6.18) (Table 3). Among the subjects with
etS, if current smokers were used as the reference, the
Rs of CVD were 0.63 (95% CI: 0.34 to 0.99) for former
mokers and 0.53 (95% CI: 0.28 to 0.94) for never smok-
rs, suggesting that smoking cessation reduces CVD risk by
pproximately 37% in male smokers with MetS. The ORs
f CHD and stroke in current smokers with MetS were the
ighest among the 6 groups and were 4.57 (95% CI: 2.57
Table 1 General Characteristics of the Stud
Characteristic Men (n 
Mean (SD)
Age (yrs) 69.0 (
Body mass index (kg/m2) 25.3 (
Systolic blood pressure (mm Hg) 137.0 (
Diastolic blood pressure (mm Hg) 77.6 (
Total cholesterol (mmol/l) 5.1 (
Triglyceride (mmol/l) 1.4 (
HDL-C (mmol/l) 1.3 (
LDL-C (mmol/l) 3.1 (
Fasting glucose (mmol/l) 6.1 (
Waist circumference (cm) 89.7 (
n (%)
Education (yrs)
0–6 258 (
72 349 (
13 336 (
Marital status
Married 873 (
Single or divorced 4 (
Widowed 66 (
Physical exercise (h/day)
1 226 (
1–3 389 (
4 328 (
Active smoking
Never 397 (
Former 313 (
Current 233 (
Secondhand smoke 188 (
Current alcohol drinking 283 (
Metabolic syndrome 327 (
Hypertension 444 (
Diabetes mellitus 148 (
Coronary heart disease 292 (
Stroke 170 (
Family history of CHD or stroke 439 (
CHD  chronic heart disease; HDL-C  high-density lipoprotein cholo 8.12) for CHD and 2.41 (95% CI: 1.24 to 4.38) for otroke. Multivariate logistic models showed no significant
nteraction between active smoking (never/former/current)
nd MetS on CHD, stroke, and CVD (p  0.69, p 
.74, and p  0.57, respectively). In contrast, no associa-
ion between active smoking and CVD risk was found in
omen, probably the result of the small number of active
moking women.
There was a clear dose-response relationship between
moking consumption (pack-years) and the adjusted ORs
ticipants
Women (n  1,391) p Value
66.6 (6.8) 0.001
25.8 (3.7) 0.002
137.6 (21.9) 0.073
76.8 (10.5) 0.077
5.5 (1.0) 0.001
1.7 (1.1) 0.001
1.4 (0.5) 0.001
3.4 (1.1) 0.001
6.2 (2.0) 0.11
86.1 (9.2) 0.001
708 (50.9) 0.001
483 (34.7)
200 (14.4)
1,094 (78.8) 0.001
7 (0.5)
290 (20.9)
389 (28.0) 0.04
510 (36.7)
491 (35.3)
1,209 (86.9) 0.001
62 (4.5)
120 (8.6)
589 (42.3) 0.001
71 (5.1) 0.001
752 (54.1) 0.001
700 (50.3) 0.13
214 (15.4) 0.86
492 (35.4) 0.03
208 (15.0) 0.05
741 (53.3) 0.001
; LDL-C  low-density lipoprotein cholesterol.y Par
943)
5.6)
3.2)
20.0)
10.2)
2.3)
0.8)
0.3)
0.8)
1.7)
9.2)
27.4)
37.0)
35.6)
92.6)
0.4)
7.0)
24.0)
41.3)
34.8)
42.1)
33.2)
24.7)
19.9)
30.0)
34.8)
47.1)
15.7)
31.0)
18.0)
46.6)f CHD and CVD in all 943 men with or without MetS
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From Around the World January 27, 2009:363–71Table 4, Fig. 1). The test for trend was significant for
HD and CVD but not for stroke.
Among never smokers (397 men and 1,209 women),
he ORs of CHD, stroke, and CVD with SHS in men were
ot significantly different based on MetS status (Table 5).
owever, in women, SHS was associated with CHD,
troke, and CVD in subjects with or without MetS. Com-
ared with those without passive smoke exposure and with-
ut MetS, the adjusted OR of CVD was 1.74 (95% CI:
.27 to 2.38) in those with MetS only, 1.72 (95% CI: 1.20
o 2.47) in those exposed to SHS only, and 2.91 (95% CI:
.03 to 4.16) for those with MetS and exposure to passive
moke. The interaction terms between SHS and MetS for
HD, stroke, and CVD were not statistically significant
p  0.66, p  0.99, and p  0.66, respectively).
Table 2 Prevalence of MetS and its Components by Tobacco
Men
Non-SHS
in Never Smokers
(n  333)
SHS
in Never Smokers
(n  64)
MetS components (%)
High blood pressure 71.0 67.3
Hyperglycemia 51.7 49.4
Hypertriglyceridemia 22.0 19.9
Low HDL-C 14.6 13.7
Central obesity 47.7 43.3
MetS 31.6 30.2
value for comparing with the group of non-secondhand smoke (SHS) in never smokers: p
MetS  metabolic syndrome; other abbreviations as in Table 1.
Table 3 ORs of CHD, Stroke, and CVD by Smoking and MetS
OR* (95% CI)
Never
MetS()
(M  268, F  554)
MetS()
(M  129, F  655)
MetS(
(M  185, F
CHD
Male (n 292) 1.00 (Ref) 1.87 (1.14–3.06) 1.95 (1.24–
Female (n 492) 1.00 (Ref) 1.70 (1.33–2.18) 1.13 (0.46–
Stroke
Male (n 170) 1.00 (Ref) 1.39 (0.78–2.47) 1.17 (0.68–
Female (n 208) 1.00 (Ref) 1.75 (1.24–2.47) 1.05 (0.30–
CVD (CHD/stroke)
Male (n 390) 1.00 (Ref) 1.83 (1.17–2.86) 1.59 (1.06–
Female (n 596) 1.00 (Ref) 1.69 (1.33–2.14) 0.93 (0.39–
Adjusted for age (years), marital status, education (years: 6, 7–12, 13), exercise (h/day
f coronary heart disease (CHD) or stroke.
CI  confidence interval; CVD  cardiovascular disease; F  female; M  male; OR  odds ratOdds ratios were determined for CHD, stroke, and
VD by tobacco exposure status (non-SHS in the never
mokers, SHS in the never smokers, and active smoking
egardless of SHS) and MetS status (Table 6). Compared
ith never smokers without MetS and SHS, the exposure
o SHS in women, active smoking in men, and MetS in
oth men and women were associated with increased risk of
VD. Those with MetS and exposure to tobacco smoke
passive or active) had greater risks of CHD, stroke, and
VD than those exposed to tobacco smoke but without
etS. For example, the ORs of CHD were 2.94 in the
emale passive smokers with MetS versus 1.73 in females
ith exposure to tobacco smoke but without MetS. Among
en, the OR of CHD was 3.18 for active smokers with
etS versus 1.57 for men exposed to SHS without MetS.
osure Status and Sex
Women
ctive
okers
 546)
Non-SHS
in Never Smokers
(n  732)
SHS
in Never Smokers
(n  477)
Active
Smokers
(n  182)
5.4* 74.0 73.3 73.1
3.1 53.6 49.5 56.0
3.0 33.8 33.3 35.1
7.3* 33.9 38.4† 40.7*
6.1* 72.2 79.0† 78.6*
7.2* 51.5 57.2† 56.4*
5, †p  0.01.
by Sex
ive Smoking Status
p Value for
Interaction of
Smoking and
MetS
rmer Current
MetS()
(M  128, F  37)
MetS()
(M  158, F  60)
MetS()
(M  75, F  60)
2.91 (1.80–4.70) 2.28 (1.43–3.64) 4.57 (2.57–8.12) 0.69
1.53 (1.03–2.65) 1.05 (0.58–1.92) 2.33 (1.34–4.07) 0.005
1.66 (0.95–2.91) 1.73 (1.06–3.09) 2.41 (1.24–4.38) 0.74
2.48 (1.10–5.56) 1.00 (0.43–2.32) 3.63 (1.95–6.76) 0.002
2.24 (1.39–3.73) 1.74 (1.13–2.67) 3.54 (2.03–6.18) 0.57
1.88 (1.23–3.17) 0.94 (0.57–1.91) 2.85 (1.62–5.01) 0.001
–3, 4), alcohol drinking (current drinkers vs. current nondrinkers), SHS, and family historyExp
A
Sm
(n
7
5
2
1
5
3and
by Act
Fo
)
 25)
3.05)
2.77)
2.00)
3.69)
2.40)
2.23)
: 1, 1io; Ref  reference group; other abbreviations as in Tables 1 and 2.
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January 27, 2009:363–71 From Around the Worlddditionally, the ORs of CHD, stroke, and CVD in the
ctive female smokers with MetS were 1.75 (95% CI: 1.07
o 2.88), 3.11 (95% CI: 1.78 to 5.32), and 2.12 (95% CI:
.34 to 3.48), respectively.
The p values for the interaction analysis can be seen in
ables 3 and 5. There was no significant interaction be-
ween active smoking and MetS among the men or of pas-
ive smoking and MetS in men and women. However,
here was a significant positive interaction between active
moking and MetS on CHD, stroke, and CVD among the
omen in this study (p  0.005, p  0.002, and
 0.001, respectively) (Table 3).
iscussion
o the best of our knowledge, this is the first study to re-
ort the joint effects of tobacco smoke exposure and meta-
olic syndrome on cardiovascular risk in a population-
ased study in China. We focused on Chinese men and
omen age 60 years or older, a group at higher risk of de-
eloping CVD. The sample was randomly selected from a
luster sample of similar residential communities and the
esponse fraction was relatively high, with only approxi-
ately 13% of eligible subjects having moved or otherwise
ailed to complete the interviews or examinations. How-
ver, there were no statistically significant differences in the
haracteristics between the responders and nonresponders.
ence, the prevalence of CVD and associated risk factors
an be generalized to similar populations in urban Beijing.
In the present study, MetS was associated with CHD and
Table 4 Smoking Consumption and OR (95% CI) of CHD, Str
Metabolic
Status
Smoking
Consumption
(Pack-Yrs)
CHD
OR* (95% CI) OR† (95% CI)
No MetS 0 1.00 —
1–20 1.18 (0.74–1.89) 1.19 (0.73–1.92)
21–40 1.52 (0.93–2.47) 1.60 (0.97–2.62)
40 1.89 (1.09–3.28) 2.08 (1.18–3.67)
p value for trend 0.012 0.003
MetS 0 1.64 (1.03–2.63) 1.68 (1.04–2.70)
1–20 2.21 (1.30–3.76) 2.27 (1.33–3.89)
21–40 2.46 (1.42–4.26) 2.57 (1.46–4.52)
40 3.19 (1.62–6.32) 3.60 (1.79–7.23)
p value for trend 0.001 0.001
Adjusted for age (years). †Adjusted for variables as defined in Table 3.
Abbreviations as in Tables 1 and 3.troke, which is consistent with previous findings (17–20,32). surthermore, active smoking in men and exposure to SHS in
omen were strongly associated with increased CVD risk in-
ependent of MetS. There was a dose-response relationship
etween pack-years of active smoking and CVD among men
nd this difference was evident regardless of MetS status. Sub-
ects with MetS exposed to tobacco smoke (active or passive)
ad greatly increased CVD risk by 48% to 193% compared
ith never smokers without MetS and without exposure to
HS. It is likely that smoking cessation could substantially
educe the risk of CVD in smokers with MetS.
We found no significant interaction between active
moking and MetS in relation to CVD in men and no sig-
ificant interaction between passive smoking and MetS in
en and women. Thus, the effects of tobacco smoke expo-
ure and MetS on the risk of cardiovascular outcomes ap-
ear to be additive in the present study. The significant
nteraction between active smoking and MetS in relation to
he risk of CVD in women suggests a synergistic effect, but
his could be a chance finding due to a very low smoking
revalence and fewer CVD events among women.
Our results are consistent with several recent studies
howing that smoking chronically induces insulin resis-
ance, with a dose-response relationship between the num-
er of cigarettes smoked and the degree of insulin resistance
nd metabolic abnormalities (28,33). There is evidence that
moking cessation improves insulin sensitivity (34) whereas
assive smoking reduces insulin sensitivity (35) and in-
reases risk of MetS (27). Because both tobacco smoke
nd MetS are independently associated with insulin re-
and CVD With or Without MetS in 943 Men
Stroke CVD (CHD/Stroke)
* (95% CI) OR† (95% CI) OR* (95% CI) OR† (95% CI)
1.00 — 1.00 —
7 (0.67–2.03) 1.21 (0.69–2.14) 1.08 (0.65–1.75) 1.15 (0.67–1.93)
3 (0.50–1.73) 0.91 (0.48–1.72) 1.25 (0.79–1.98) 1.32 (0.83–2.10)
9 (0.90–3.17) 1.63 (0.85–3.14) 2.20 (1.30–3.72) 2.35 (1.37–4.05)
0.26 0.45 0.006 0.001
6 (0.97–2.85) 1.50 (0.87–2.60) 1.83 (1.18–2.84) 1.81 (1.17–2.82)
7 (0.90–3.10) 1.60 (0.85–3.01) 2.06 (1.24–3.44) 2.09 (1.25–3.50)
8 (0.41–1.87) 0.80 (0.37–1.73) 2.28 (1.34–3.89) 2.38 (1.38–4.10)
0 (0.81–4.00) 1.66 (0.73–3.75) 2.82 (1.43–5.59) 2.99 (1.49–5.99)
0.32 0.57 0.001 0.001oke,
OR
1.1
0.9
1.6
1.6
1.6
0.8
1.8istance and because insulin resistance may contribute to
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From Around the World January 27, 2009:363–71ccelerated atherosclerosis, these 2 risk factors may be
inked through this common pathophysiology to in-
reased risk of CVD.
In the past 30 years, the prevalence of traditional risk fac-
ors for CVD (i.e., cigarette smoking, dyslipidemia, and hyper-
Figure 1
Dose-Response Relation Between Smoking
Consumption and Adjusted ORs of CHD, Stroke,
and CVD in Men With or Without MetS
Blue diamonds  without metabolic syndrome (MetS); open squares  with
MetS. CHD  coronary heart disease; CVD  cardiovascular disease; OR 
odds ratio.ension) has gradually declined in the U.S., with smoking srevalence decreasing from 50% in 1960 to about 23% in
000. However, during this same period, the prevalence of
besity and MetS has increased dramatically in the U.S. (36).
n China, smoking rates remain high (1) and cessation rates
ow (9.5% of all ever smokers have quit) (37), whereas being
verweight and MetS are rapidly increasing with changes in
ifestyle (e.g., excessive caloric intake and lack of physical activ-
ty) (21,22). It is likely that the growing double epidemics of
moking and MetS in China will greatly and rapidly increase
he burden of CVD from traditional risk factors (such as
moking, SHS, hypertension) acting together with new risk
actors (obesity, MetS, and diabetes).
Considering that both tobacco use and MetS are the 2
eading causes of preventable death in China, our findings
ave important public health implications. Our results em-
hasize that public health policies are needed to control
moking, SHS, and MetS. In terms of the implications for
linical practice, smokers or those exposed to passive smoke
ith MetS have very high CVD risk and should be targeted
or intensive interventions.
tudy limitations. The present study has several limita-
ions. The cross-sectional nature of the data limits causal infer-
nces. The underreporting of smoking, including history of
elf-reported active and passive smoking, could also bias the
ssociation between smoking and CVD towards null. The
ata on smoking status should not have been affected by dif-
erential reporting bias in CVD cases versus noncases because
hey were collected before physical examination or the diseases
efined by hospitalization.
The relatively low prevalence of SHS exposure (42.3%) in
omen could be attributable to 2 reasons. First, the prevalence
f current smoking in elderly men in our study was much
ower (24.7%) than that in the general population (1), thus
educing the exposure to SHS in women in close contact to
lderly men. Second, exposure to SHS was restricted to
assive smoking in the past 10 years to minimize recall
rror, but this means fewer opportunities to be exposed
o SHS during this limited time period compared with
omen in the general population who may have had
onsiderable exposure to SHS earlier than the 10-year
eriod analyzed in this study.
To reduce the bias of “ill quitter effect,” former smokers
ere defined as those who had stopped smoking for at least 2
ears. Furthermore, the pattern of smoking cessation in our
ubjects is consistent with other Chinese data (37,38). Some
ubjects could have died young from smoking- or other CVD-
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January 27, 2009:363–71 From Around the Worldelated risk factors before the survey, making our participants
he survivors. It is likely that the effects of smoking and MetS
n CVD are stronger in younger people than in older individ-
als. Additionally, limiting SHS to a 10-year period might
xplain in part the lower prevalence (19.9%) of SHS in these
lder men; they are likely retired and have few opportunities
or work-related SHS exposure. Similarly, because of the low
revalence of current smoking among women, the men in our
tudy were less likely to be exposed to SHS in the home. This
ay explain why we didn’t find a significant association of
HS and CVD in men. We observed no significant associa-
ion between active smoking and risks of CVD in women
robably due to their low prevalence of active smoking among
omen.
Table 5 OR (95% CI) of CHD, Stroke, and CVD by SHS, MetS
OR (95% CI) by SH
Non-SHS
MetS()
(M  220, F  327)
MetS()
(M  113, F  406)
CHD
Male (n  90) 1.00 (Ref) 1.80 (1.06–3.06)
Female (n  431) 1.00 (Ref) 1.76 (1.27–2.45)
Stroke
Male (n  61) 1.00 (Ref) 1.23 (0.66–2.29)
Female (n  172) 1.00 (Ref) 1.91 (1.18–3.09)
CVD (CHD/stroke)
Male (n  137) 1.00 (Ref) 1.76 (1.08–2.86)
Female (n  516) 1.00 (Ref) 1.74 (1.27–2.38)
Adjusted for variables as defined in Table 3 but not including SHS.
Abbreviations as in Tables 1 to 3.
Table 6 OR (95% CI) of CHD, Stroke, and CVD by Tobacco E
OR (95
Non-SHS in Never Smokers
MetS()
(M  223, F  326)
MetS()
(M  110, F  405) (M 
CHD
Male (n 292) 1.00 (Ref) 1.91 (1.13–3.24) 1.57
Female (n 492) 1.00 (Ref) 1.76 (1.27–2.45) 1.73
Stroke
Male (n 170) 1.00 (Ref) 1.30 (0.72–2.35) 0.70
Female (n 208) 1.00 (Ref) 1.91 (1.18–3.09) 1.85
CVD (CHD/stroke)
Male (n 390) 1.00 (Ref) 1.84 (1.13–2.97) 1.04
Female (n 596) 1.00 (Ref) 1.74 (1.27–2.38) 1.73Adjusted for variables as in Table 3, but not including SHS.
Abbreviations as in Tables 1 to 3.When considering all these factors as well as the poten-
ial for misclassification in ascertaining SHS exposure, the
elationship between tobacco smoke exposure (especially
HS), MetS, and CVD is likely to be underestimated in
ur study. Finally, because of small numbers of former
mokers and the lack of detailed information about the
uration of SHS, a dose-response relationship of duration
f quitting in men and the quantity of SHS exposure in
omen could not be analyzed.
onclusions
ur study shows that cigarette smoking in men and SHS
xposure in women are highly prevalent in elderly Chinese.
Sex in 1,606 Never Smokers
osure Status*
p Value for Interaction
of SHS and MetS
SHS
MetS()
(M  48, F  227)
MetS()
(M  16, F  246)
1.54 (0.73–3.24) 1.69 (0.50–5.77) 0.53
1.74 (1.19–2.54) 2.96 (2.05–4.28) 0.66
0.71 (0.33–2.21) 0.92 (0.41–4.04) 0.71
1.85 (1.07–3.20) 2.90 (1.74–4.84) 0.99
1.07 (0.53–2.17) 1.41 (0.43–4.62) 0.69
1.72 (1.20–2.47) 2.91 (2.03–4.16) 0.66
ure Status, MetS, and Sex
by Tobacco Exposure Status*
HS in Never Smokers Active Smokers
)
 228)
MetS()
(M  15, F  248)
MetS()
(M  341, F  83)
MetS()
(M  202, F  99)
–3.30) 1.80 (0.53–6.11) 1.90 (1.26–2.88) 3.18 (2.04–4.97)
–2.53) 2.94 (2.04–4.25) 1.34 (0.71–2.16) 1.75 (1.07–2.88)
–2.04) 0.94 (0.45–3.37) 1.43 (0.98–2.82) 2.21 (1.38–4.18)
–3.19) 2.91 (1.75–4.86) 1.03 (0.44–2.39) 3.11 (1.78–5.32)
–2.09) 1.48 (0.53–4.41) 1.46 (1.01–2.12) 2.53 (1.68–3.82)
–2.48) 2.93 (2.05–4.19) 1.06 (0.59–1.72) 2.12 (1.34–3.48), and
S Expxpos
% CI)
S
MetS(
49, F
(0.75
(1.19
(0.32
(1.07
(0.52
(1.20
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From Around the World January 27, 2009:363–71obacco smoke exposure (including active and passive
moking) increased the prevalence of CHD, stroke, and
VD in the subjects with or without MetS after adjusting
or other CVD risk factors. These findings collectively sug-
est that cigarette smoking and SHS, 2 modifiable risk fac-
ors, are strongly associated with increased CVD indepen-
ent of MetS. The growing double epidemics of MetS and
obacco smoke exposure (both active smoking and SHS)
ill dramatically increase the risk of CVD in the Chinese
opulation.
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